Audit of the use of screening computed tomography (CT) head in Stage III non-small cell lung cancer patients

被引：0
|
作者：
Evans, T. [1 ]
Siah, T. [2 ]
Simms, A. [1 ]
机构：
[1] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Univ Edinburgh, Edinburgh, Midlothian, Scotland
来源：
CLINICAL ONCOLOGY | 2016年 / 28卷
关键词：
D O I：
10.1016/j.clon.2016.04.031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S11 / S12
页数：3
相关论文
共 50 条
  • [21] What is the role for surgery in patients with stage III non-small cell lung cancer?
    Vandenbroucke, Elke
    De Ryck, Frederic
    Surmont, Veerle
    van Meerbeeck, Jan P.
    CURRENT OPINION IN PULMONARY MEDICINE, 2009, 15 (04) : 295 - 302
  • [22] Concurrent chemoradiotherapy for elderly patients with stage III non-small cell lung cancer
    Kang, Ki Mun
    Jeong, Bae Kwon
    Ha, In Bong
    Chai, Gyu Young
    Lee, Gyeong Won
    Kim, Hoon Gu
    Kang, Jung Hoon
    Lee, Won Seob
    Kang, Myoung Hee
    RADIATION ONCOLOGY JOURNAL, 2012, 30 (03): : 140 - 145
  • [23] Chemoradiation in older patients with stage III non-small cell lung cancer (NSCLC)
    Ng, Dawn M.
    Sun, Alex
    Coate, Linda
    Ma, Clement
    Bezjak, Andrea
    Brade, Anthony
    Burkes, Ronald L.
    Cho, John
    Feld, Ronald
    Liu, Geoff
    Shepherd, Frances
    Leighl, Natasha B.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S858 - S858
  • [24] Feasibility of Hypofractionated Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer
    Van Zyp, N. Van der Voort
    Hashimzadah, M.
    Kouwenhoven, E.
    Maas, K.
    Oosterhuis, W.
    Walraven, I.
    Belderbos, J.
    Mast, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S633 - S633
  • [25] Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study
    Schoenmaekers, Janna
    Hofman, Paul
    Bootsma, Gerben
    Westenend, Marcel
    de Booij, Machiel
    Schreurs, Wendy
    Houben, Ruud
    De Ruysscher, Dirk
    Dingemans, Anne-Marie
    Hendriks, Lizza E. L.
    EUROPEAN JOURNAL OF CANCER, 2019, 115 : 88 - 96
  • [26] Serum lipidome screening in patients with stage I non-small cell lung cancer
    Klupczynska, Agnieszka
    Plewa, Szymon
    Kasprzyk, Mariusz
    Dyszkiewicz, Wojciech
    Kokot, Zenon J.
    Matysiak, Jan
    CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 19 (04) : 505 - 513
  • [27] Serum lipidome screening in patients with stage I non-small cell lung cancer
    Agnieszka Klupczynska
    Szymon Plewa
    Mariusz Kasprzyk
    Wojciech Dyszkiewicz
    Zenon J. Kokot
    Jan Matysiak
    Clinical and Experimental Medicine, 2019, 19 : 505 - 513
  • [28] Prognostic factors for overall survival of stage III non-small cell lung cancer patients on computed tomography: A systematic review and meta-analysis
    van Laar, Myra
    van Amsterdam, Wouter A. C.
    van Lindert, Anne S. R.
    de Jong, Pim A.
    Verhoeff, Joost J. C.
    RADIOTHERAPY AND ONCOLOGY, 2020, 151 : 152 - 175
  • [29] Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features
    Khorrami, Mohammadhadi
    Jain, Prantesh
    Bera, Kaustav
    Alilou, Mehdi
    Thawani, Rajat
    Patil, Pradnya
    Ahmad, Usman
    Murthy, Sudish
    Stephans, Kevin
    Fu, Pingfu
    Velcheti, Vamsidhar
    Madabhushi, Anant
    LUNG CANCER, 2019, 135 : 1 - 9
  • [30] Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
    Price, Katharine A. R.
    Azzoli, Christopher G.
    Gaspar, Laurie E.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2008, 20 (03) : 204 - 209
12345